Functional impairment in COPD patients: the impact of anxiety and depression
- PMID: 11110109
- DOI: 10.1176/appi.psy.41.6.465
Functional impairment in COPD patients: the impact of anxiety and depression
Abstract
The authors examined the relationship between functional status and comorbid anxiety and depression and the relationship between utilization of health care resources and psychopathology in elderly patients with chronic obstructive pulmonary disease (COPD). Elderly male veterans (N = 43) with COPD completed anxiety, depression, and functional status measures. The authors constructed regression models to explore the contribution of COPD severity, medical burden, depression, and anxiety to the dependent variables of functional impairment and health care utilization. Anxiety and depression contributed significantly to the overall variance in functional status of COPD patients, over and above medical burden and COPD severity, as measured by the 8 scales of the Medical Outcomes Study (MOS) 36-item Short Form Health Survey. Surprisingly, medical burden and COPD severity did not contribute significantly to overall variance in functional status. Few patients were receiving any treatment for anxiety or depression.
Similar articles
-
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.Respir Med. 2000 Sep;94(9):841-6. doi: 10.1053/rmed.2000.0804. Respir Med. 2000. PMID: 11001074
-
Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.Europace. 2013 Oct;15(10):1468-74. doi: 10.1093/europace/eut072. Epub 2013 Apr 21. Europace. 2013. PMID: 23608028
-
Understanding the impact of symptoms on the burden of COPD.Respir Res. 2017 Apr 21;18(1):67. doi: 10.1186/s12931-017-0548-3. Respir Res. 2017. PMID: 28431503 Free PMC article. Review.
-
Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression.Psychosomatics. 2006 Jul-Aug;47(4):312-9. doi: 10.1176/appi.psy.47.4.312. Psychosomatics. 2006. PMID: 16844889 Clinical Trial.
-
Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2014 Nov 13;9:1289-306. doi: 10.2147/COPD.S72073. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 25419126 Free PMC article. Review.
Cited by
-
A randomized placebo-controlled trial of paroxetine for the management of anxiety in chronic obstructive pulmonary disease (PAC Study).J Multidiscip Healthc. 2018 Jun 27;11:287-293. doi: 10.2147/JMDH.S166022. eCollection 2018. J Multidiscip Healthc. 2018. PMID: 29983572 Free PMC article.
-
Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function.Int J Chron Obstruct Pulmon Dis. 2019 Aug 21;14:1855-1866. doi: 10.2147/COPD.S213607. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31686798 Free PMC article.
-
Patients with COPD with higher levels of anxiety are more physically active.Chest. 2013 Jul;144(1):145-151. doi: 10.1378/chest.12-1873. Chest. 2013. PMID: 23370503 Free PMC article.
-
Depression in COPD--management and quality of life considerations.Int J Chron Obstruct Pulmon Dis. 2006;1(3):315-20. doi: 10.2147/copd.2006.1.3.315. Int J Chron Obstruct Pulmon Dis. 2006. PMID: 18046868 Free PMC article. Review.
-
Improving Physiological, Physical, and Psychological Health Outcomes: A Narrative Review in US Veterans with COPD.Int J Chron Obstruct Pulmon Dis. 2022 Jun 1;17:1269-1283. doi: 10.2147/COPD.S339323. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35677347 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical